Trastuzumab Not Yet Recruiting Phase 1 Trials for Cancer, Breast Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03716180DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC